Mark B. Templeton
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nutanix Stock Underperforms Market Amid Broker Analysis. Nutanix shares have recently declined more sharply than the broader market, drawing attention from financial analysts. Recent broker reports suggest the stock is a focus for investment strategies, while comparisons with peers like MongoDB and Google highlight its position among value-oriented tech names. The company's trailing P/E of 12.7 and average analyst target of $77.79 provide context for these ongoing discussions.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Transaction History
| ANET | ▼ Sell | Open Market | 700 | $141K | 10/1/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 500 | $101K | 10/1/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 1,800 | $368K | 10/1/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 1,800 | $370K | 10/1/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 200 | $41K | 10/1/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 1,300 | $254K | 9/8/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 700 | $137K | 9/8/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 1,000 | $197K | 9/8/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 1,700 | $337K | 9/8/2026 | View on chart |
| ANET | ▼ Sell | Open Market | 300 | $60K | 9/8/2026 | View on chart |
| ANET | ▲ Buy | Option Exercise | 538 | $0 | 8/20/2026 | View on chart |
| ANET | ▲ Buy | Option Exercise | 971 | $0 | 5/20/2026 | View on chart |
| ANET | ▲ Buy | Option Exercise | 971 | $0 | 2/20/2026 | View on chart |
| NTNX | ▲ Buy | Grant | 4,588 | $0 | 12/12/2025 | View on chart |
| ANET | ▲ Buy | Option Exercise | 971 | $0 | 11/20/2025 | View on chart |
| ANET | ▲ Buy | Option Exercise | 971 | $0 | 8/20/2025 | View on chart |
| ANET | ▲ Buy | Option Exercise | 844 | $0 | 5/20/2025 | View on chart |
| ANET | ▲ Buy | Option Exercise | 844 | — | 2/20/2025 | View on chart |
| NTNX | ▲ Buy | Grant | 3,646 | $0 | 12/13/2024 | View on chart |
| ANET | ▲ Buy | Option Exercise | 212 | $0 | 11/20/2024 | View on chart |
| ANET | ▲ Buy | Option Exercise | 211 | $0 | 8/20/2024 | View on chart |
| ANET | ▲ Buy | Option Exercise | 372 | $0 | 5/20/2024 | View on chart |
| ANET | ▲ Buy | Option Exercise | 373 | $0 | 2/20/2024 | View on chart |
| NTNX | ▲ Buy | Grant | 6,088 | $0 | 12/8/2023 | View on chart |
| ANET | ▲ Buy | Option Exercise | 372 | $0 | 11/20/2023 | View on chart |
| ANET | ▲ Buy | Option Exercise | 373 | — | 8/21/2023 | View on chart |
| NTNX | ▲ Buy | Grant | 3,389 | $0 | 7/24/2023 | View on chart |
| HCAT | ▲ Buy | Grant | 12,505 | $0 | 6/14/2023 | View on chart |
| HCAT | ▲ Buy | Grant | 5,359 | $0 | 6/14/2023 | View on chart |
| ANET | ▲ Buy | Option Exercise | 510 | $0 | 5/22/2023 | View on chart |
| ANET | ▲ Buy | Option Exercise | 511 | $0 | 2/21/2023 | View on chart |
| ANET | ▲ Buy | Option Exercise | 510 | $0 | 11/21/2022 | View on chart |
| ANET | ▲ Buy | Option Exercise | 511 | $0 | 8/22/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 11,677 | $0 | 6/14/2022 | View on chart |
| ANET | ▲ Buy | Option Exercise | 692 | $0 | 5/20/2022 | View on chart |
| ANET | ▲ Buy | Option Exercise | 696 | $0 | 2/22/2022 | View on chart |
| ANET | ▼ Sell | Gift | 18,800 | $0 | 12/21/2021 | View on chart |
| ANET | ▼ Sell | Gift | 18,800 | $0 | 12/21/2021 | View on chart |
| ANET | ▲ Buy | Option Exercise | 692 | $0 | 11/22/2021 | View on chart |
| ANET | ▲ Buy | Option Exercise | 174 | $0 | 8/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Arista Networks (ANET) sees CEO stock sale amid AI focus
Chief executive sold about $34 million of ANET shares, reducing her personal holding. Analysts note the company's growing role in AI‑focused data‑center networking as enterprise AI spending rises. Market commentary also points to interest‑rate concerns that can influence high‑growth tech valuations, reflected in ANET's trailing P/E of 63.8. The stock trades near its 52‑week high, with an average analyst target of $244.
Arista Networks (ANET) sees CEO stock sale amid AI focus. Chief executive sold about $34 million of ANET shares, reducing her personal holding. Analysts note the company's growing role in AI‑focused data‑center networking as enterprise AI spending rises. Market commentary also points to interest‑rate concerns that can influence high‑growth tech valuations, reflected in ANET's trailing P/E of 63.8. The stock trades near its 52‑week high, with an average analyst target of $244.